SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for SCYNEXIS INC (SCYX) (CIK 0001178253) (SCYX) — Mar 28, 2019

SCYNEXIS INC (SCYX) (CIK 0001178253)
Date: March 28, 2019 · CIK: 0001178253 · Accession: 0000000000-19-006038

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-230449

Date
March 27, 2019
Author
Marco Taglietti
Form
UPLOAD
Company
SCYNEXIS INC (SCYX) (CIK 0001178253)

Letter

March 27, 2019 Marco Taglietti Chief Executive Officer Scynexis, Inc. 1 Evertrust Plaza, 13th Floor Jersey City, NJ 07302-6548 Re:Scynexis Inc. Registration Statement on Form S-3 Filed March 22, 2019 File No. 333-230449 Dear Dr. Taglietti: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Tonya K. Aldave at (202) 551-3601 with any questions. Sincerely, Division of Corporation Finance Office of Healthcare & Insurance cc: Brett White, Esq.

Show Raw Text
March 27, 2019
Marco Taglietti
Chief Executive Officer
Scynexis, Inc.
1 Evertrust Plaza, 13th Floor
Jersey City, NJ 07302-6548
Re:Scynexis Inc.
Registration Statement on Form S-3
Filed March 22, 2019
File No. 333-230449
Dear Dr. Taglietti:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Tonya K. Aldave at (202) 551-3601 with any questions.
Sincerely,
Division of Corporation Finance
Office of Healthcare & Insurance
cc:       Brett White, Esq.